Should I be worried about Filoviruses (Ebola and Marburg)?
- If you are in the affected area high
- WHO assessed the risk in the Democratic Republic of the Congo as “very high” on 14 August 2026, an assessment repeated in its 6 November bulletin. That bulletin says the assessment is being revised. According to WHO
- If you are elsewhere in the same country or region high
- WHO’s “very high” assessment applies to the Democratic Republic of the Congo nationally, not just its affected health zones. The assessment was made on 14 August 2026 and repeated on 6 November. According to WHO
- If you are travelling there soon high
- WHO’s 6 November bulletin repeats its 14 August assessment of high risk for countries sharing land borders with the Democratic Republic of the Congo. This is a geographic assessment, not a rating of your individual risk while travelling; WHO advises against general travel restrictions. According to WHO
- If you are elsewhere in the world low
- WHO assessed global risk as low on 14 August 2026 and repeated that assessment in its 6 November bulletin. WHO says the assessment is being revised. According to WHO
What is happening
Current filovirus activity is driven mainly by the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo, concentrated in Ituri and North Kivu and documented in WHO notices since at least 8 October 2026. WHO’s 6 November bulletin reported official totals of 10,668 confirmed cases and 5,198 deaths through 3 November, with recent transmission in 51 health zones across eight affected provinces. A newer Arab News report published on 18 November attributed 11,376 confirmed cases and 5,568 deaths to WHO, but these remain media-relayed, unverified figures rather than independently verified official totals. WHO reported no new cases in Kenya or Nigeria in its latest bulletin, while Ethiopia declared its Marburg outbreak over on 26 January 2026. Officials are using isolation, laboratory testing, contact tracing, infection prevention, safe burials and cross-border surveillance, although insecurity and incomplete contact follow-up continue to hinder the response.
- Ebola disease caused by Bundibugyo virus - Democratic Republic of the Congo WHO · 8 Oct 2026
- Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo, Kenya and Nigeria WHO · 6 Nov 2026
- Strain-specific Ebola jab trials to start in DR Congo next week: WHO Arab News · 18 Nov 2026
- Marburg virus disease- Ethiopia WHO · 26 Jan 2026
Who is affected and how it spreads
Ebola and Marburg viruses can cause severe disease in people and other primates. They spread mainly through direct contact with a sick person’s blood or other body fluids, contaminated objects, or exposure during unsafe care or burials. People providing care and those involved in burials can therefore be exposed; these viruses are not mainly spread through casual airborne contact in the way flu is. Vaccines and antibody treatments licensed for Zaire Ebola cannot be assumed effective or approved for Bundibugyo Ebola or Marburg.
- Transmission dynamics and control of Ebola virus disease (EVD): a review. Europe PMC · 10 Oct 2014
- Marburg Virus Disease–United Republic of Tanzania WHO · 14 Feb 2025
- The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps. Europe PMC · 29 Jul 2022
- Marburg virus disease- Ethiopia WHO · 21 Nov 2025
What we are watching
- Updated official DRC totals and whether new infections are declining.
- New unlinked infections or sustained transmission outside DRC.
- Official confirmation that Kenya and Nigeria have completed their outbreak responses.
- Improved contact follow-up and access to affected communities despite insecurity.
- WHO’s revised regional and global risk assessment, and verified results from Bundibugyo-specific vaccine or treatment trials.
Updates
- · The short answer now clarifies that WHO’s high cross-border assessment concerns countries bordering DRC, rather than every traveller’s individual risk.
- · Newer media reporting attributes 11,376 confirmed cases and 5,568 deaths to WHO and describes plans for Bundibugyo-specific vaccine trials; the figures remain unverified against a primary release.
- · Later media reports add case and death totals and report plans for strain-specific vaccine trials, while the cited WHO risk assessment remains unchanged pending revision.
- · The page now distinguishes the newer media-relayed totals from WHO’s 6 November official figures.
- · A newer media report attributes 11,376 confirmed cases and 5,568 deaths to WHO; these totals remain unverified against a primary release.
Sources
- Ebola disease caused by Bundibugyo virus - Democratic Republic of the Congo WHO · 8 Oct 2026
- Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo, Kenya and Nigeria WHO · 6 Nov 2026
- Strain-specific Ebola jab trials to start in DR Congo next week: WHO Arab News · 18 Nov 2026
- Marburg virus disease- Ethiopia WHO · 26 Jan 2026
- Transmission dynamics and control of Ebola virus disease (EVD): a review. Europe PMC · 10 Oct 2014
- Marburg Virus Disease–United Republic of Tanzania WHO · 14 Feb 2025
- The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps. Europe PMC · 29 Jul 2022
- Marburg virus disease- Ethiopia WHO · 21 Nov 2025